UniProt ID | RN139_HUMAN | |
---|---|---|
UniProt AC | Q8WU17 | |
Protein Name | E3 ubiquitin-protein ligase RNF139 | |
Gene Name | RNF139 {ECO:0000312|HGNC:HGNC:17023} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 664 | |
Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein . |
|
Protein Description | E3-ubiquitin ligase; acts as a negative regulator of the cell proliferation through mechanisms involving G2/M arrest and cell death. Required for MHC class I ubiquitination in cells expressing the cytomegalovirus protein US2 before dislocation from the endoplasmic reticulum (ER). Affects SREBP processing by hindering the SREBP/SCAP complex translocation from the ER to the Golgi, thereby reducing SREBF2 target gene expression. Required for INSIG1 ubiquitination. May be required for EIF3 complex ubiquitination. May function as a signaling receptor.. | |
Protein Sequence | MAAVGPPQQQVRMAHQQVWAALEVALRVPCLYIIDAIFNSYPDSSQSRFCIVLQIFLRLFGVFASSIVLILSQRSLFKFYTYSSAFLLAATSVLVNYYASLHIDFYGAYNTSAFGIELLPRKGPSLWMALIVLQLTFGIGYVTLLQIHSIYSQLIILDLLVPVIGLITELPLHIRETLLFTSSLILTLNTVFVLAVKLKWFYYSTRYVYLLVRHMYRIYGLQLLMEDTWKRIRFPDILRVFWLTRVTAQATVLMYILRMANETDSFFISWDDFWDLICNLIISGCDSTLTVLGMSAVISSVAHYLGLGILAFIGSTEEDDRRLGFVAPVLFFILALQTGLSGLRPEERLIRLSRNMCLLLTAVLHFIHGMTDPVLMSLSASHVSSFRRHFPVLFVSACLFILPVLLSYVLWHHYALNTWLFAVTAFCVELCLKVIVSLTVYTLFMIDGYYNVLWEKLDDYVYYVRSTGSIIEFIFGVVMFGNGAYTMMFESGSKIRAFMMCLHAYFNIYLQAKNGWKTFMNRRTAVKKINSLPEIKGSRLQEINDVCAICYHEFTTSARITPCNHYFHALCLRKWLYIQDTCPMCHQKVYIEDDIKDNSNVSNNNGFIPPNETPEEAVREAAAESDRELNEDDSTDCDDDVQRERNGVIQHTGAAAEEFNDDTD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAAVGPPQQ ------CCCCCCHHH | 15.74 | 22814378 | |
72 | Phosphorylation | SSIVLILSQRSLFKF HHHHHHHCCCCHHHH | 19.29 | 24719451 | |
75 | Phosphorylation | VLILSQRSLFKFYTY HHHHCCCCHHHHHCH | 30.44 | 24719451 | |
228 | Phosphorylation | LQLLMEDTWKRIRFP HHHHCCCCHHHCCCC | 21.41 | - | |
230 | Ubiquitination | LLMEDTWKRIRFPDI HHCCCCHHHCCCCHH | 39.79 | - | |
247 | Phosphorylation | VFWLTRVTAQATVLM HHHHHHHHHHHHHHH | 15.12 | 20068231 | |
251 | Phosphorylation | TRVTAQATVLMYILR HHHHHHHHHHHHHHH | 11.33 | 20068231 | |
255 | Phosphorylation | AQATVLMYILRMANE HHHHHHHHHHHHHCC | 7.82 | 20068231 | |
341 | Phosphorylation | LALQTGLSGLRPEER HHHHHCCCCCCHHHH | 36.81 | 24719451 | |
449 | Phosphorylation | TLFMIDGYYNVLWEK HHHHHCCHHHHHHHH | 6.52 | - | |
450 | Phosphorylation | LFMIDGYYNVLWEKL HHHHCCHHHHHHHHH | 12.34 | - | |
460 | Phosphorylation | LWEKLDDYVYYVRST HHHHHCCCEEECCCC | 7.04 | 30576142 | |
466 | Phosphorylation | DYVYYVRSTGSIIEF CCEEECCCCCCHHHH | 27.38 | 30576142 | |
469 | Phosphorylation | YYVRSTGSIIEFIFG EECCCCCCHHHHHHE | 22.08 | 25332170 | |
485 | Phosphorylation | VMFGNGAYTMMFESG EEECCCCEEEEECCC | 9.14 | 25332170 | |
491 | Phosphorylation | AYTMMFESGSKIRAF CEEEEECCCHHHHHH | 36.78 | 30576142 | |
528 | Ubiquitination | NRRTAVKKINSLPEI CHHHHHHHHHCCCCC | 40.29 | 29967540 | |
531 | Phosphorylation | TAVKKINSLPEIKGS HHHHHHHCCCCCCCC | 49.10 | 28450419 | |
625 | Phosphorylation | VREAAAESDRELNED HHHHHHHCCHHCCCC | 36.92 | 30278072 | |
634 | Phosphorylation | RELNEDDSTDCDDDV HHCCCCCCCCCCHHH | 38.17 | 30278072 | |
635 | Phosphorylation | ELNEDDSTDCDDDVQ HCCCCCCCCCCHHHH | 47.87 | 30278072 | |
652 | Phosphorylation | RNGVIQHTGAAAEEF HHCCCCCCCHHHHHH | 16.49 | 23403867 | |
663 | Phosphorylation | AEEFNDDTD------ HHHHCCCCC------ | 46.61 | 20068067 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RN139_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RN139_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RN139_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
INSI1_HUMAN | INSIG1 | physical | 20068067 | |
EIF3A_HUMAN | EIF3A | physical | 20068067 | |
SRBP2_HUMAN | SREBF2 | physical | 19706601 | |
SCAP_HUMAN | SCAP | physical | 19706601 | |
INSI1_HUMAN | INSIG1 | physical | 22143767 | |
INSI2_HUMAN | INSIG2 | physical | 22143767 | |
HMDH_HUMAN | HMGCR | physical | 22143767 | |
AUP1_HUMAN | AUP1 | physical | 23223569 | |
UB2G2_HUMAN | UBE2G2 | physical | 23223569 | |
1C07_HUMAN | HLA-C | physical | 19720873 | |
HM13_HUMAN | HM13 | physical | 19720873 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
144700 | Renal cell carcinoma (RCC) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-625; SER-634; THR-635AND THR-663, AND MASS SPECTROMETRY. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-663, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-663, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-663, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-663, AND MASSSPECTROMETRY. |